Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Philadelphia, PA
SEC filing record 1 source field available
Fiscal year end
30 September
abrdn Life Sciences Investors has filed 515 SEC EDGAR filings since 13 Dec 1995

SEC filing history

Showing 51-75 of 383 matching filings.

Per page
25
Current page
3
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Mar 2025
Reporting date
11 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
NPORT-P File 811-06565

NPORT-P filing

Filing date
28 Feb 2025
Reporting date
31 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Feb 2025
Reporting date
26 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Feb 2025
Reporting date
13 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Feb 2025
Reporting date
12 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Feb 2025
Reporting date
03 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Feb 2025
Reporting date
30 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Jan 2025
Reporting date
29 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Dec 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
3

OWNERSHIP DOCUMENT

Filing date
20 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
N-CEN File 811-06565

N-CEN filing

Filing date
16 Dec 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
N-CSR File 811-06565

N-CSR

Filing date
09 Dec 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
NPORT-P File 811-06565

NPORT-P filing

Filing date
27 Nov 2024
Reporting date
30 Sep 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
N-PX File 811-06565

N-PX filing

Filing date
03 Sep 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
NPORT-P File 811-06565

NPORT-P filing

Filing date
28 Aug 2024
Reporting date
30 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
27 Aug 2024
Reporting date
23 Aug 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
40-17G File 811-06565

40-17G

Filing date
15 Aug 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
18 Jul 2024
Reporting date
16 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jun 2024
Reporting date
26 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
25 Jun 2024
Reporting date
24 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .